Skip to main content
Top

Cancer and Metastasis Reviews

Issue 2/2017

Content (17 Articles)

Preface

David Menter

Normal platelet function

Michael Holinstat

Platelet “first responders” in wound response, cancer, and metastasis

David G. Menter, Scott Kopetz, Ernest Hawk, Anil K. Sood, Jonathan M. Loree, Paolo Gresele, Kenneth V. Honn

The influence of platelet membranes on tumour cell behaviour

LA Coupland, EJ Hindmarsh, EE Gardiner, CR Parish

Open Access

Platelet-activating factor podoplanin: from discovery to drug development

Ai Takemoto, Kenichi Miyata, Naoya Fujita

Platelets, circulating tumor cells, and the circulome

Preeti Kanikarla-Marie, Michael Lam, David G. Menter, Scott Kopetz

Open Access

Platelets and cancer angiogenesis nexus

Marek Z. Wojtukiewicz, Ewa Sierko, Dominika Hempel, Stephanie C. Tucker, Kenneth V. Honn

Open Access

Platelet RNA signatures for the detection of cancer

Nik Sol, Thomas Wurdinger

The potential role of platelets in the consensus molecular subtypes of colorectal cancer

Michael Lam, Jason Roszik, Preeti Kanikarla-Marie, Jennifer S. Davis, Jeffrey Morris, Scott Kopetz, David G. Menter

Open Access

Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention

Argentina Ornelas, Niki Zacharias-Millward, David G. Menter, Jennifer S. Davis, Lenard Lichtenberger, David Hawke, Ernest Hawk, Eduardo Vilar, Pratip Bhattacharya, Steven Millward

Open Access

Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?

Marek Z. Wojtukiewicz, Dominika Hempel, Ewa Sierko, Stephanie C. Tucker, Kenneth V. Honn

Platelet-targeted pharmacologic treatments as anti-cancer therapy

P. Gresele, S. Momi, M. Malvestiti, M. Sebastiano

NON-THEMATIC REVIEW

Cytokine-induced senescence for cancer surveillance

Thomas Wieder, Ellen Brenner, Heidi Braumüller, Oliver Bischof, Martin Röcken

NON-THEMATIC REVIEW

Cleavage and phosphorylation: important post-translational modifications of galectin-3

Xiaoge Gao, Jingjie Liu, Xiangye Liu, Liantao Li, Junnian Zheng

Open Access CLINICAL

Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis

E. J. van Helden, C. W. Menke-van der Houven van Oordt, M. W. Heymans, J. C. F. Ket, R. van den Oord, H. M. W. Verheul

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine